🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the change in patient-reported out...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-08
Trial ID
NCT01216072
Treatments Being Tested
This study will investigate the efficacy, safety and tolerability of a new ...
Status
Terminated
Location
Teva Investigational Site 10192
Start Date
2012-03
Trial ID
NCT01578785
Treatments Being Tested
The purpose of this study is to determine if higher compliance and adherenc...
Status
Completed
Location
Teva Investigational Site
Start Date
2008-12
Trial ID
NCT00819000
Treatments Being Tested
The primary objective of the study is to assess the clinical efficacy of Re...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2004-02-16
Trial ID
NCT00078338
This study, REbif® vs Glatiramer acetate in relapsing multiple sclerosis (M...
Status
Completed
Location
Please Contact U.S. Medical Information Located in
Start Date
2010-02
Trial ID
NCT01034579
Treatments Being Tested
This is an open-label, multicenter study conducted at approximately 20 site...
Status
Completed
Location
Multiple Locations
Start Date
2010-07
Trial ID
NCT01167426
Treatments Being Tested
Randomized study designed to look at the difference in relapse rates betwee...
Status
Terminated
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00202995
Treatments Being Tested
This is an open-label, randomized, multi-center, parallel-arm study to asse...
Status
Completed
Location
Teva Investigational Site 10706
Start Date
2013-06
Trial ID
NCT01874145
Treatments Being Tested
The primary objective of the study is to evaluate the real-world clinical e...
Status
Completed
Location
Research Site
Start Date
2016-05
Trial ID
NCT02776072
This study will: * Explore whether GA decreases inflammation more on the 3...
Status
Completed
Location
Jacobs Neurological Institute
Start Date
2007-09
Trial ID
NCT00937157
Treatments Being Tested